Product logins

Find logins to all Clarivate products below.


Electrophysiology Mapping and Ablation Devices | Market Insights | Japan | 2024

The Japanese EP mapping and ablation device market has recovered largely from the COVID-19 pandemic and will resume moderate growth over the remainder of the forecast period, supported by increasing AF ablation procedure volumes and the emergence as well as adoption of novel technology, including pulsed field ablation and hybrid AF ablation systems.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for EP mapping and ablation devices in Japan from 2019 through 2032.

Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – United States
The US EP mapping and ablation device market will experience strong growth through 2035, driven by the rapid expansion of AF ablation procedures, particularly PFA devices, and the approval of…
Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will see modest growth through 2035, driven by recent technological and clinical advances, including the introduction of nextgeneration devices, expanding…